Cosmos Health Inc

Research Cosmos Health Inc (COSM) on Bullrun: market cap USD 11.16M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 11.16M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 65.27M-USD 19.14M-USD 8.50M12.1%-0.63USD 715.67KUSD 3.78MUSD 18.42M
FY2024USD 54.43M-USD 16.18M-USD 8.14M7.9%-1.17USD 315.11KUSD 4.11MUSD 24.53M
FY2023USD 53.38M-USD 18.54M-USD 16.95M8.1%-2.15USD 3.83MUSD 3.24MUSD 36.04M
FY2022USD 50.35M-USD 13.83M-USD 14.94M11.8%-33.16USD 20.75MUSD 5.02MUSD 39.28M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 11.16Mn/an/an/a
20252025-12-31USD 20.53Mn/an/an/a
20242024-12-31USD 15.81Mn/an/an/a
20232023-12-29USD 18.90Mn/an/an/a
20222022-12-30USD 48.29Mn/an/an/a
20212021-12-31USD 2.31Mn/an/an/a

About Cosmos Health Inc

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Cosmos Health Inc's market cap?

Cosmos Health Inc's market capitalization is USD 11.16M.

What does Cosmos Health Inc do?

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names.